{"cord_uid":"yy77veid", "sourcedb":"PMC", "sourceid":"PMC6817825", "divid":23, "text":"The details of the formulations for in vivo delivery experiments are currently poorly or indirectly described; these should be stated explicitly. Order of mixing, stock concentrations, and other factors can be important, so these details should be made available. A lot of detail that might apply throughout currently appears under the heading "Cas12a RNP delivery in primary NK cells" -if those details indeed apply broadly (e.g. to in vivo experiments), they should appear under a more general heading.", "project":"cdlai_CORD-19", "denotations":[]}